跳至主要内容
临床试验/JPRN-UMIN000022150
JPRN-UMIN000022150已完成未知

The prospective single-center study on the efficacy and safety of rituximab for the treatment of adult and geriatric patients with primary nephrotic syndrome. - The study on efficacy and safety of rituximab for adult and geriatric patients with nephrotic syndrome.

Tokyo Metropolitan Geriatric Hospital0 个研究点目标入组 50 人开始时间: 2016年5月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Case that showed at least one of the following terms should be excluded. 1)Patient who have the severe allergy for rituximab. 2)Patient who has the severe disease, such as heart failure,liver diseases(hepatitis B positive)and end stage renal disease. 3)Patient who has the severe bacterial,fungal or viral infection. 4)Patient who could not experienced informd consent. 5)The doctor decides that the patient is inappropriate to enroll in this study.

研究者

相似试验